Resum
Protein therapeutics cannot reach the brain in sufficient amounts because of their low permeability across the blood-brain barrier. Here we report a new family of bicyclic peptide shuttles, BrainBikes, capable of increasing transport of proteins, including antibody derivatives, in a human cell-based model of the blood-brain barrier.
Idioma original | Anglès |
---|---|
Pàgines (de-a) | 7-11 |
Nombre de pàgines | 5 |
Revista | RSC Chemical Biology |
Volum | 5 |
Número | 1 |
DOIs | |
Estat de la publicació | Publicada - de gen. 2024 |